Back
Jazz Pharmaceuticals PLC Vs. Monopar Therapeutics Industry Stock Comparison
Sell
34
JAZZ
Jazz Pharmaceuticals PLC
Last Price:
$122.90
Seasonality Move:
21.65%
Sell
48
MNPR
Monopar Therapeutics
Last Price:
$41.84
Seasonality Move:
-14.17%
Sell
34
Jazz Pharmaceuticals PLC (JAZZ)
is a Sell
Is Jazz Pharmaceuticals PLC a Buy, Sell or Hold?
-
The current Jazz Pharmaceuticals PLC [JAZZ] share price is $122.92. The Score for JAZZ is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
JAZZ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $40.33. The Score for MNPR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JAZZ Stock Price Chart
What is Jazz Pharmaceuticals PLC's stock price today?
-
The Jazz Pharmaceuticals PLC share price today is $122.92Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JAZZ is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $40.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
JAZZ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.84 | Sell |
Relative Strength Index (14 RSI): | 32.69 | Sell |
Chaikin Money Flow: | -1633598 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.74 - 142.56) | Sell |
Bollinger Bands (100): | (118.2 - 134.66) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.01 | Buy |
Relative Strength Index (14 RSI): | 56.65 | Buy |
Chaikin Money Flow: | 2380 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.07 - 39.49) | Buy |
Bollinger Bands (100): | (19.65 - 39.65) | Buy |
JAZZ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 134.86 | Sell |
20-day SMA: | 137.08 | Sell |
50-day SMA: | 131.51 | Sell |
200-day SMA: | 118.13 | Buy |
8-day EMA: | 132.1 | Sell |
20-day EMA: | 134.84 | Sell |
50-day EMA: | 132.25 | Sell |
200-day EMA: | 123 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.86 | Buy |
20-day SMA: | 34.79 | Buy |
50-day SMA: | 37.86 | Buy |
200-day SMA: | 17.05 | Buy |
8-day EMA: | 38.75 | Buy |
20-day EMA: | 37.13 | Buy |
50-day EMA: | 35.15 | Buy |
200-day EMA: | 21.74 | Buy |
Jazz Pharmaceuticals PLC Earnings Growth & JAZZ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.72 per share, a decrease next quarter of $1.37 per share, an increase this year of $3.20 per share, and a decrease next year of $0.32 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Jazz Pharmaceuticals PLC Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |